Drugs / Emdogain
Emdogain
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT02972788 | Feb 2017 → Sep 2018 | periodontal disorder | University of Nebraska | Completed | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT05565079 | Oct 2022 → Oct 2024 | gingival recession | University of Louisville | Completed | No outcome recorded |
| Phase 4 | NCT05507047 | Jan 2017 → Jan 2020 | osteosclerosis | T.C. Dumlupınar Üniversitesi | Completed | No outcome recorded |
| Phase 4 | NCT03059966 | Mar 2014 → Dec 2016 | gingival recession | Rio de Janeiro State University | Completed | No outcome recorded |
Also used as a comparator or background therapy in 4 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 42 trials | ||||||
| Phase 4 | NCT06250088 Comparator | Mar 2024 → Jun 2025 | — | Universidad Complutense de Madrid | Unknown | No outcome recorded |
| Phase 4 | NCT01030666 Background | Apr 2007 → Jan 2011 | periodontitis | Peter Eickholz | Terminated | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT07292870 Comparator | Aug 2025 → Dec 2027 expected | periodontitis, aggressive | Universitaire Ziekenhuizen KU Leuven | Recruiting | No outcome recorded |
| — | NCT07230522 Comparator | Mar → Jul 2024 | periodontitis | Medical University of Sofia | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Emdogain | “12 patients will receive a coronally positioned tunnel with a regenerative tissue matrix (AlloDerm RTM, BioHorizons) and a porcine derived enamel matrix derivative (Emdogain,...” NCT05565079 ↗5“Evaluation of the Inflammatory and Healing Profile After Root Coverage With Emdogain®” NCT03059966 ↗ |
| Known as | EMD | “Periodontal Surgery Infrabony defects reported in this analysis are treated by application of EMD (Emdogain®, Institut Straumann AG, Basel, Switzerland).” NCT01030666 ↗1“Emdogain (EMD) - test” NCT06250088 ↗ |
| Known as | Enamel Matrix Protein | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05507047 ↗ |
| Known as | Enamel Matrix Proteins Derivative | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02972788 ↗ |
| Modality | Protein / enzyme biologic | “enamel matrix protein derivative” NCT02972788 ↗ |
| Route | Other | “Enamel matrix proteins derivative will be placed in deep periodontal pocket during routine periodontal maintenance therapy.” NCT02972788 ↗ |